TTRX

Turn Therapeutics
TTRX

22 hedge funds and large institutions have $1.84M invested in Turn Therapeutics in 2025 Q4 according to their latest regulatory filings, with 22 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

Holders
22
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$399K
2
+$274K
3
+$218K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$126K
5
XT
XTX Topco
Cayman Islands
+$105K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Millennium Management
1
Millennium Management
New York
$377K
WSC
2
Wellington Shields & Co
New York
$259K
DI
3
DDFG Inc
California
$206K
Vanguard Group
4
Vanguard Group
Pennsylvania
$119K
XT
5
XTX Topco
Cayman Islands
$99.2K
BBHC
6
Brown Brothers Harriman & Co
New York
$93.3K
Citadel Advisors
7
Citadel Advisors
Florida
$82.7K
HighTower Advisors
8
HighTower Advisors
Illinois
$77.6K
RW
9
RVW Wealth
California
$70.9K
Jane Street
10
Jane Street
New York
$67.6K
Geode Capital Management
11
Geode Capital Management
Massachusetts
$67.5K
MMA
12
Miracle Mile Advisors
California
$63K
TS
13
Tamar Securities
California
$59.1K
Bank of America
14
Bank of America
North Carolina
$55.6K
LPL Financial
15
LPL Financial
California
$51.2K
Morgan Stanley
16
Morgan Stanley
New York
$39.4K
HCM
17
Hodges Capital Management
Texas
$39.4K
BTI
18
Blue Trust Inc
Georgia
$4.42K
Wells Fargo
19
Wells Fargo
California
$3.94K
Royal Bank of Canada
20
Royal Bank of Canada
Ontario, Canada
$1K
PK
21
Pflug Koory
Nebraska
$670
TRCT
22
Tower Research Capital (TRC)
New York
$540